This study clearly showed that Doxil® (as compared to doxorubicin (Adriamycin)) reduced the incidence of cardiotoxicity in women with breast cancer without compromising outcomes. Thus Doxil® could be included in standard multi-drug regimens for the treatment of breast cancer. Doxil is one of several new "liposomal" chemotherapy drugs.
|
All times are GMT -7. The time now is 11:36 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021